Results 51 to 60 of about 1,634,298 (165)

Neurotrophin receptors expression and JNK pathway activation in human astrocytomas

open access: yesBMC Cancer, 2007
Background Neurotrophins are growth factors that regulate cell growth, differentiation and apoptosis in the nervous system. Their diverse actions are mediated through two different transmembrane – receptor signaling systems: Trk receptor tyrosine kinases
Maraziotis Theodore   +4 more
doaj   +1 more source

Plasmalogen attenuates the development of hepatic steatosis and cognitive deficit through mechanism involving p75NTR inhibition

open access: yesRedox Biology, 2021
Emerging evidence suggests that the reduction of ethanolamine plasmalogen (PlsEtn) is associated with in Alzheimer's disease and metabolic diseases. However, the mechanistic bases for PlsEtn on the these diseases are not well understood. Plasmalogens are
Yanjun Liu   +10 more
doaj   +1 more source

Cancer pain: current practice and emerging targets

open access: yesBritish Journal of Pharmacology, EarlyView.
Cancer pain (CP) arises from a complex interplay between the tumour and its microenvironment. Many patients experience a mixed pain phenotype that encompasses nociceptive, neuropathic and neuroinflammatory mechanisms, and vary across tumour type and disease stage. Despite decades of intensive research, the mainstay of cancer pain treatment is still non‐
Yi Ye   +5 more
wiley   +1 more source

In vivo function of NGF/TrkA signaling in the cholinergic neurons of the murine basal forebrain [PDF]

open access: yes, 2005
The neurotrophins are a family of secreted proteins that potently regulate diverse neuronal responses. The neurotrophin nerve growth factor (NGF) and its receptors TrkA and p75 are well characterized to control survival, differentiation and function of ...
Mueller, Markus
core   +1 more source

The p75 neurotrophin receptor in AgRP neurons is necessary for homeostatic feeding and food anticipation

open access: yeseLife, 2020
Networks of neurons control feeding and activity patterns by integrating internal metabolic signals of energy balance with external environmental cues such as time-of-day.
Brandon Podyma   +8 more
doaj   +1 more source

Supplementary Figure 3 from The Biological Role of the Low-Affinity p75 Neurotrophin Receptor in Esophageal Squamous Cell Carcinoma

open access: yes, 2006
Supplementary Figure 3 from The Biological Role of the Low-Affinity p75 Neurotrophin Receptor in Esophageal Squamous Cell ...
Tomoyuki Okumura (3536159)   +7 more
core   +1 more source

Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains [PDF]

open access: yes, 2009
Several lines of evidence implicate BDNF in the pathophysiology of psychiatric illness. BDNF polymorphisms have also been associated with the risk of schizophrenia and mood disorders.
Dunham, Jason S.   +17 more
core   +1 more source

p75 neurotrophin receptor and fenretinide-induced signaling in neuroblastoma [PDF]

open access: yesCancer Chemotherapy and Pharmacology, 2013
Neuroblastoma is the most common extracranial solid tumor of childhood. The retinoic acid analogue, fenretinide (4-hydroxyphenyl retinamide; 4-HPR), induces apoptosis in neuroblastoma cells in vitro and is currently in clinical trials for children with refractory neuroblastoma.
Veena R, Ganeshan, Nina F, Schor
openaire   +2 more sources

Early Retinal UCHL1 Dysregulation Coupled With Synaptic Loss Reflects Alzheimer's Disease Severity

open access: yesAdvanced Science, Volume 13, Issue 63, 12 November 2026.
This study identifies synapse‐enriched deubiquitinase UCHL1 as an early Aβ‐responsive regulator of retinal synaptopathy in Alzheimer's disease. Retinal UCHL1 loss accompanies excitatory synapse degeneration, p75NTR activation, and neuroinflammation, and predicts Braak stage and cognitive decline. Aβ42 fibrils trigger synaptic and UCHL1 depletion before
Altan Rentsendorj   +25 more
wiley   +1 more source

Neurotrophin receptor agonists and antagonists as therapeutic agents: An evolving paradigm

open access: yesNeurobiology of Disease, 2017
Neurodegenerative disorders are prevalent, complex and devastating conditions, with very limited treatment options currently available. While they manifest in many forms, there are commonalities that link them together.
Sylvia Josephy-Hernandez   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy